Department of Ophthalmology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, 9 Jiaowei Road, Liuhongqiao, Wenzhou, 325000, Zhejiang, China.
Int Ophthalmol. 2024 Sep 6;44(1):372. doi: 10.1007/s10792-024-03291-7.
Trabeculectomy, a primary surgical treatment for glaucoma, often employs mitomycin C (MMC) to reduce scar formation and improve surgical outcomes. However, the optimal application method of MMC, whether by injection or sponge, remains a subject of debate. This meta-analysis aims to compare injectable and sponge-based MMC application in terms of efficacy and safety, focusing on various clinical outcomes in glaucoma patients.
A comprehensive literature search of Scopus, MEDLINE, EMBASE, Ovid, Chinese biomedical literature database, China National Knowledge Infrastructure, and Cochrane Library was done for eligible studies that report data of glaucoma patients who were administered MMC by injection or sponge application during trabeculectomy. Outcomes of interest included intraocular pressure (IOP) reduction, bleb appearance grading (height, extent, vascularity), use of anti-glaucoma medications, and rates of complete success, qualified success, and failure. Data were reported as weighted mean differences (WMD) or odds ratios (OR) with confidence intervals (CI). The random-effects inverse-variance model with DerSimonian-Laird estimate of tau was employed, with continuity correction applied where necessary.
A total of 15 studies with 1276 participants were included. The meta-analysis revealed no significant difference in IOP reduction between patients treated by MMC injection and sponge application (WMD = - 0.434). Significant differences were observed in bleb appearance grading scores for height (WMD = - 0.170) and extent (WMD = 0.174), with substantial heterogeneity. The use of anti-glaucoma medications was significantly lower in the injection group (WMD = - 0.274). However, there were no significant differences in the rates of complete success, qualified success, and failure. The study demonstrated moderate to high heterogeneity across various outcomes.
This meta-analysis indicated that while both injection and sponge methods of MMC application during trabeculectomy were equally effective for IOP reduction, they differ in their impact on bleb morphology and postoperative medication requirement. The findings highlight the need for individualized treatment approaches in glaucoma surgery, taking into account the specific needs and characteristics of each patient.
小梁切除术是治疗青光眼的主要手术方法,常采用丝裂霉素 C(MMC)减少瘢痕形成,改善手术效果。然而,MMC 的最佳应用方法,无论是注射还是海绵,仍存在争议。本荟萃分析旨在比较注射和海绵基 MMC 在疗效和安全性方面的应用,重点关注青光眼患者各种临床结局。
通过 Scopus、MEDLINE、EMBASE、Ovid、中国生物医学文献数据库、中国国家知识基础设施和 Cochrane 图书馆全面检索符合条件的研究,这些研究报告了在小梁切除术中接受 MMC 注射或海绵应用的青光眼患者的数据。感兴趣的结局包括眼压(IOP)降低、滤过泡外观分级(高度、范围、血管化)、抗青光眼药物使用以及完全成功、合格成功和失败的比例。数据以加权均数差(WMD)或比值比(OR)及其置信区间(CI)报告。采用随机效应逆方差模型,采用 DerSimonian-Laird 估计 tau,必要时应用连续性校正。
共有 15 项研究,涉及 1276 名参与者。荟萃分析显示,接受 MMC 注射和海绵应用治疗的患者之间 IOP 降低无显著差异(WMD=-0.434)。滤过泡外观分级评分的高度(WMD=-0.170)和范围(WMD=0.174)有显著差异,存在较大异质性。注射组抗青光眼药物的使用显著降低(WMD=-0.274)。然而,完全成功、合格成功和失败的比例无显著差异。研究表明,在各种结局中存在中度至高度异质性。
本荟萃分析表明,虽然小梁切除术中 MMC 注射和海绵应用两种方法在降低 IOP 方面同样有效,但在滤过泡形态和术后药物需求方面存在差异。研究结果强调了在青光眼手术中需要采用个体化治疗方法,考虑到每个患者的具体需求和特征。